Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn.

BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.

To realise the potential of medical device data and maintain security protocols in a more connected medtech reality, network architecture must evolve.

Becton, Dickinson and Company (BD) has announced its submission of an application to the FDA for an at-home human papillomavirus (HPV) test.

Trividia Health UK has launched the TRUEplus 5-Bevel Pen Needles in the country, marking the product's first entry outside the US.

Founder Juan José Chacón-Quiros discusses how Establishment Labs is transforming breast reconstruction and aesthetics with innovative, patient-focused solutions.

Regulatory and supply chain pressures place scaling medical device companies under strain. Expert partners can help ease these pain points.

Baxter’s share price declined by almost 23% on 31 July following the disclosure of disappointing Q2 2025 results that prompted the company to trim its 2025 profit outlook.

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

Olympus and private equity firm Revival Healthcare Capital have co-founded a new endoluminal robotics startup named Swan EndoSurgical Robotics.